Dare Bioscience (DARE) Goodwill & Intangibles (2017)
Dare Bioscience's (DARE) quarterly Goodwill & Intangibles came in at $5.2 million in Q4 2017, down 59.73% on a QoQ basis from $12.9 million in Q3 2017.
Dare Bioscience (DARE) Goodwill & Intangibles (2017) Analysis & Trends
Dare Bioscience (DARE) has 1 years of Goodwill & Intangibles data on file, last reported at $5.2 million in Q4 2017.
- Quarterly Goodwill & Intangibles changed N/A year-over-year to $5.2 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $5.2 million (changed N/A YoY) and the FY2017 annual result came in at $5.2 million, changed N/A from the prior year.
- Goodwill & Intangibles fell to $5.2 million in Q4 2017, from $12.9 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $12.9 million in Q3 2017 to a low of $5.2 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dare Bioscience | 12.36 Mn | -256,055.23 | -132,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 5.19 Mn |
| Sep 30, 2017 | 12.88 Mn |